DALMAB
ADALIMUMAB
Public price
4,17 MAD
Active substance
ADALIMUMAB
Laboratory
COOPER PHARMA
What is this medicine?
HADLIMA (adalimumab-bwwd) is a biosimilar to HUMIRA (adalimumab) that acts as a tumor necrosis factor (TNF) blocker.
Verified summary
ADALIMUMAB, SOLUTION INJECTABLE EN SERINGUE PREREMPLIE DE 0.4 ML, 40 MG, BOITE DE 2 SERINGUES PREREMPLIES AVEC 2 TAMPONS D’ALCOOL
Common uses
moderately to severely active rheumatoid arthritis,moderately to severely active polyarticular juvenile idiopathic arthritis,active psoriatic arthritis,active ankylosing spondylitis,moderately to severely active Crohn’s disease,moderately to severely active ulcerative colitis,moderate to severe chronic plaque psoriasis,moderate to severe hidradenitis suppurativa,non-infectious intermediate, posterior, and panuveitis
Class
tumor necrosis factor (TNF) blocker
Laboratory
COOPER PHARMA
Hospital price
3,88 MAD
Strength
40 MG
Form
SOLUTION INJECTABLE EN SERINGUE PREREMPLIE DE 0.4 ML
Presentation
BOITE DE 2 SERINGUES PREREMPLIES AVEC 2 TAMPONS D’ALCOOL
Commercial status
Non Commercialisé
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 4,17 MAD
Available presentations and strengths
Medicines with the same active substance
HUMIRA 40MG
40 MG · 1 BOITE 2 SERINGUE PREREMPLIE
0,00 MAD
HUMIRA 40MG
40 MG · 1 BOITE 2 STYLO PRE-REMPLI
0,00 MAD
HUMIRA
20 MG / 0,2 ML · BOITE DE 2
3,26 MAD
YUFLYMA
40 MG / 0,4 ML · BOITE DE 2 STYLOS PRÉ-REMPLIS AVEC CHACUN 1 TAMPON D'ALCOOL
4,17 MAD
HULIO
40 MG / 0,8 ML · BOITE DE 2
4,18 MAD
HULIO
40 MG / 0,8 ML · BOITE DE 2
4,18 MAD
HYRIMOZ
40 MG / 0,8 ML · BOITE DE 2 STYLOS PREREMPLIS
4,52 MAD
AMGEVITA
40 MG · BOITE DE 2
4,82 MAD
AMGEVITA
40 MG · BOITE DE 2
4,82 MAD
HUMIRA
40 MG / 0,4 ML · BOITE DE 2
5,84 MAD
HUMIRA
40 MG / 0.4 ML · BOITE DE 1
5,84 MAD
HUMIRA
80 MG / 08 ML · BOITE DE 1
6,12 MAD